1 / 15

Leukemia & Lymphoma Keith Rischer, RN, MA, CEN

Leukemia & Lymphoma Keith Rischer, RN, MA, CEN. Leukemia. Patho Loss of regulation in cell division, causes proliferation of malignant leukocytes Classification based on predominant cell of origin Lymphoid Myeloid Acute or Chronic

karenrbarnes
Download Presentation

Leukemia & Lymphoma Keith Rischer, RN, MA, CEN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Leukemia & Lymphoma Keith Rischer, RN, MA, CEN

  2. Leukemia Patho • Loss of regulation in cell division, causes proliferation of malignant leukocytes Classification based on predominant cell of origin • Lymphoid • Myeloid Acute or Chronic Lymphocytic leukemiaAcute lymphocytic leukemia (ALL)most common w/peds • 5 yr survival 80% peds/40% w/adults Chronic lymphocytic leukemia (CLL)-most common w/adults • 73% survival rate Myelogenous leukemiaAcute myelogenous leukemia (AML) 20% survival rate Chronic myelogenous leukemia (CML)

  3. Leukemia: Etiology • Chromosomal changes • Chemical Agents-Benzene • Chemotherapy-Alkylating Agents • Viruses-Retroviruses • Radiation • Unknown factors

  4. Leukemia Sx- Clinical Manifestations • Anemia • Fatigue and weakness • Bleeding • Fever and Infections • Weight loss-joint pain • Mouth sores • Hepatosplenomegaly & Lymphadenopathy Diagnosis

  5. General Treatment of Leukemia Chemotherapy • Induction therapy- attempts to induce or bring about remission. • Consolidation therapy - after remission achieved-eliminate remaining cells • Maintenance therapy- treatment with lower doses of same drugs every 3-4 weeks • Combination therapy • Stem cell transplant • Bone marrow transplant

  6. Nursing Management Acute Many emotional-psychosocial needs/support • Communicate tx plan-expected course • Protective Isolation/Neutropenic Precautions • Educate!! • Chemo-manage side effects • Spiritual care

  7. Neutropenia • Severe decrease in neutrophils-secondary to chemo or immunosuppressive therapy • Sx: decreased immune/inflammatory response-masks infection…low grade fever significant >100.4 • Nursing Management: • Neutropenic precautions • obtain pan cultures • start IV abx • assess for septic shock

  8. Lymph System • Consists of: lymphatic capillaries, ducts, lymph nodes, lymph fluid • Function: • Returns excess interstitial fluid to the blood • Absorbs fatty acids • Produces immune cells • Lymph nodes: Filtration of bacteria and foreign particles carried by lymph fluid.

  9. Lymphoma – Hodgkin’s Patho Incidence Clinical Manifestations • Enlargement of cervical, axillary or inguinal lymph nodes • *Wt Loss, *Fever and chills,*Night sweats (these correlate with a worse prognosis, B sx’s) - Fatigue and weakness • Tachycardia Diagnosis

  10. Lymphoma – Hodgkin’s Treatment: Based on stage of the disease • Radiation alone or with chemotherapy Objective: • least amt of tx to achieve cure yet minimize short-term & long-term complications Nursing Management • pain control • managing side effects • psychosocial support

  11. Non-Hodgkin’s Lymphomas Patho Prevalence Categories • Low grade (indolent) • Intermediate grade (aggressive) • High grade (very aggressive) • Affects all ages Manifestations

  12. Non-Hodgkin’s lymphomas Diagnosis Treatment • Radiation if just stage I • Chemotherapy involves multidose/multiagent regimen • Holistic nursing management-same as previous blood disorders…pain control, management of SE, psychosocial support, • Spiritual care-multidisciplinary team

  13. Multiple Myeloma Patho • excess production of plasma cells w/resultant myeloma proteins destroys bone/bone marrow Incidence Clinical manifestations (develop slowly and insidiously) • Skeletal pain (esp pelvis, spine & ribs) *Major manifestation, presents first. • Osteolytic lesions; can see in skull, vertebrae & ribs • Hypercalcemia from bony degeneration • Anemia, thrombocytopenia, & granulocytopenia

  14. Multiple Myeloma Diagnosis • Lab, x-rays, bone marrow • Urine has Bence Jones protein Collaborative management: • Radiation • Chemo Nursing Management • Ambulation & adequate hydration • Ambulate w/care • Pain control • Infection control • Emotional/spiritual support

More Related